Johnson & Johnson (JNJ): FY25 Q3 earnings call, Oct 14, 2025

No Kalshi or Polymarket word markets were listed for Johnson & Johnson’s Oct 14, 2025 earnings call (FY25 Q3). The transcript is searchable below (quotes of at most 25 words).

Updated

Transcript

quotes of at most 25 words

Speaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.

1 match for “Procedure”; 1 quoted, at least 25 words apart.

Darren Snellgrovecompanyprepared

…In cardiovascular, electrophysiology delivered growth of 9.7% versus prior year, driven by procedure growth, commercial execution, VariPulse, and other new products, and strength in competitive…

Agents: this page as TSV at /api/v1/appearances/johnson-and-johnson:2025-10-14:earnings_call · words: /api/v1/brief?appearance=johnson-and-johnson:2025-10-14:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP